[Elsevier] Response to correspondence on ‘Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind,

paik Post time Yesterday 15:36 | Show all posts |Read mode
This post will be closed automatically in 2026-09-17 15:34
Reward10points


        Response to correspondence on ‘Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study’ by Mysler et al

page:  e91-e93

journal:Annals of the Rheumatic Diseases

Authors:Roy Fleischmann; Orsolya Nagy; Jingchen Ren; Eduardo Mysler

Published date:2026-9-

DOI:10.1016/j.ard.2026.05.026

PDF link:https://www.sciencedirect.com/sc ... 003496726003043/pdf

Article link:https://doi.org/10.1016/j.ard.2026.05.026

Article Source:Elsevier BV


Remark:
Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time Yesterday 15:36 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply
paik Post time Yesterday 15:43 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    210


Return to the list